Cytochrome P450/redox partner fusion enzymes: biotechnological and toxicological prospects

Author： McLean Kirsty J   Girvan Hazel M   Munro Andrew W  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.3, Iss.6, 2007-12, pp. : 847-863

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer treatment and pharmacogenetics of cytochrome P450 enzymes

By Schaik Ron  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 513-522

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome p450 enzymes and cardiovascular disease

By Hunter Arwen L   Cruz Rani P   Cheyne Bo M   McManus Bruce M   Granville David J  

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 12, 2004-12 ,pp. : 1053-1060

NRC Research Press

Access to resources Recommend Favorite

Effects of icaritin on cytochrome P450 enzymes in rats

By Liang Dong-Lou   Zheng Shuang-Li  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 4, 2014-04 ,pp. : 301-305

Govi-Verlag

Access to resources Recommend Favorite

The role of pharmacogenetically-variable cytochrome P450 enzymes in

By Howard Lisa A   Sellers Edward M   Tyndale Rachel F  

Pharmacogenomics, Vol. 3, Iss. 2, 2002-03 ,pp. : 185-199

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of Cytochrome P450 Enzymes in Tumours

By  

Current Pharmacogenomics, Vol. 2, Iss. 3, 2004-09 ,pp. : 243-254

Bentham Science Publishers

Access to resources Recommend Favorite